Don't Know

MCAN Study Published in Pediatric Allergy, Immunology, and Pulmonology

Sponsoring Program Name: 
Merck Childhood Asthma Network, Inc.
A study published in Pediatric Allergy, Immunology, and Pulmonology examines how tailored evidence-based interventions assist low-income communities with high rates of pediatric asthma morbidity. The study, which examined data from MCAN Phase 1 Program Sites, assessed impact by examining rate of hospitalizations and daily use of a controller medication.

Background: Asthma continues to be a significant public health issue for children. The extent to which tailored evidence-based interventions address the needs of children at varied levels of risk in the community is unclear.

Objective: Using data from five impoverished communities with high levels of pediatric asthma morbidity, this study assessed morbidity outcomes associated with tailored evidence-based interventions after stratifying children for risk based on two variables that reflect control, severity, and behavior: hospitalizations and daily use of a controller medication.

Methods: A pre/post evaluation (n=721) was used to categorize and analyze change in outcomes for four groups of patients: patients with one or more hospitalizations in the past 12 months with or without a baseline controller medication use, and no hospitalizations in the past 12 months with or without baseline controller medication use.

Results: Patients with one or more hospitalizations in the past 12 months and no baseline controller use made the biggest gains in several areas, including the largest percent increase in daily controller medication usage and asthma action plans, and the largest decrease in days and nights of symptoms. However, other groups made larger gains in reducing school days missed and emergency department visits and increasing parent confidence, consistent with the notion that community-based interventions can help a diverse set of patients make progress.

Conclusion: Practitioners in low-income communities where there are varying levels of resources and disease severity can tailor interventions to each child's needs and make substantial gains in outcomes across a range of risk profiles

Click here to view the full study.

Contact Name: 
Merck Childhood Asthma Network, Inc.
Contact Phone: 
(202) 326-5230
Resource Category: 
Literacy Level: 

Full Transcript-Getting Ahead of Asthma: How States are Implementing Primary Prevention to Reduce the Onset of Asthma

Looking for more resources on how primary prevention can reduce the onset of asthma? View this resource to learn key themes from the full Podcast Episode 13 transcript.

The Massachusetts Strategic Plan for Asthma is the first state asthma plan in the nation to address how primary prevention can reduce the onset of asthma. This Strategic Plan outlines goals and funding mechanisms to promote partnerships and services that ensure healthy populations stay that way: healthy and asthma-free.

Contact Name: 
EPA Asthma Team
Language: 
Literacy Level: 

NACI Partner Profile: Where Are they Now?

Sponsoring Program: 
National Asthma Control Initiative (NACI) Takes a Big Bite of the Big Apple

2011 may have seen the end of a two-year project funded through the National Asthma Control Initiative (NACI) to Woodhull Medical and Mental Health Center and the North Brooklyn Health Network, both part of The New York City Health and Hospitals Corporation (HHC).

But what happened next was no ending. 

HHC Woodhull’s asthma program managers were so successful at coupling asthma-care training (plus one-on-one coaching for health professionals) with focused outreach to patients and families that HHC’s C-suite executives made a critical decision.

Read the full story by clicking on the link. 

Resource Type: 
Language: 
Literacy Level: 

Pages